Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
First-time investors can benefit greatly from expert advice. Learn key strategies to navigate the investment landscape effectively.
28,248 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Driverless tech is moving from sci-fi to street reality. This article argues that one incredible autonomous vehicle s...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
SpaceX joining the Nasdaq-100 would be a major headline, but the real questions are about risk, weighting, and portfo...
Amazon stock has cooled after a strong run, but bulls argue AI investments, AWS momentum, and ad growth could fuel a ...
After Johnson Johnson released its latest earnings, investors wonder: is this stock a buy? This guide breaks down the...
Investors woke up to a modest rally in Intel as executives highlighted strong demand and expansion plans. This articl...
Nvidia leads the AI chip race, but AMD has momentum and strategic wins. This guide breaks down who is the better arti...
A major fund disclosed a sizable NEU share sale. This article unpacks what the move signals, how to interpret it, and...
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...
If BoA's three conditions for rate hikes come true, Bitcoin could face renewed pressure from rising borrowing costs a...
Investors have watched Micron stock keep going lower despite upbeat earnings. This deep dive explains the forces behi...